{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:48:16Z","timestamp":1793332096805,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019035","name":"Science and Technology Program of Hubei Province","doi-asserted-by":"publisher","award":["WJ2025M191"],"award-info":[{"award-number":["WJ2025M191"]}],"id":[{"id":"10.13039\/501100019035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903863"],"award-info":[{"award-number":["81903863"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21602089"],"award-info":[{"award-number":["21602089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1303502"],"award-info":[{"award-number":["2022YFA1303502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022CFB171"],"award-info":[{"award-number":["2022CFB171"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB1021"],"award-info":[{"award-number":["2023AFB1021"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejmech.2026.118922","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:03:19Z","timestamp":1777993399000},"page":"118922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis, and evaluation of indole-pyridine chalcone derivatives as novel HK2 inhibitors to modulate macrophage glycolysis and inflammation for IBD treatment"],"prefix":"10.1016","volume":"314","author":[{"given":"Yawei","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4488-8008","authenticated-orcid":false,"given":"Mengzhu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118922_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1734-1140(11)70575-8","article-title":"Treatment of inflammatory bowel disease (IBD)","volume":"63","author":"Pithadia","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2026.118922_bib2","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.3748\/wjg.v23.i36.6628","article-title":"Glucocorticosteroid therapy in inflammatory bowel diseases: from clinical practice to molecular biology","volume":"23","author":"Dubois-Camacho","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2026.118922_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tips.2016.10.014","article-title":"Novel targeted therapies for inflammatory bowel disease","volume":"38","author":"Coskun","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.118922_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJMct1209614","article-title":"Tumor necrosis factor inhibitors for inflammatory bowel disease","volume":"369","author":"Nielsen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.118922_bib5","first-page":"43","article-title":"Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial, Lancet Gastroenterol","volume":"8","author":"Sandborn","year":"2023","journal-title":"Hepatol."},{"key":"10.1016\/j.ejmech.2026.118922_bib6","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(22)00466-4","article-title":"Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial","volume":"399","author":"Ferrante","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118922_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.63","article-title":"Loss of response to Anti-TNFs: definition, epidemiology, and management","volume":"7","author":"Roda","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.ejmech.2026.118922_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.118922_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1103231","article-title":"Role of mitochondria-bound HK2 in rheumatoid arthritis fibroblast-like synoviocytes","volume":"14","author":"Torres","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.118922_bib10","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.cmet.2021.11.004","article-title":"Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis","volume":"33","author":"Hinrichsen","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2026.118922_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115986","article-title":"Research progress of hexokinase 2 in inflammatory-related diseases and its inhibitors","volume":"264","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118922_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2016.05.076","article-title":"Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan","volume":"166","author":"Wolf","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118922_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2024.09.009","article-title":"Neutrophil extracellular traps promote M1 macrophage polarization in gouty inflammation via targeting hexokinase-2, Free","volume":"224","author":"Tan","year":"2024","journal-title":"Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2026.118922_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12964-022-00943-y","article-title":"HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways","volume":"20","author":"Bao","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2026.118922_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/sjg.SJG_470_17","article-title":"Pokeweed antiviral protein attenuates liver fibrosis in mice through regulating Wnt\/Jnk mediated glucose metabolism","volume":"24","author":"Zhang","year":"2018","journal-title":"Saudi J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2026.118922_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.714598","article-title":"Activated pancreatic stellate cells enhance the warburg effect to cause the malignant development in chronic pancreatitis","volume":"11","author":"Tao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.118922_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.molimm.2021.10.007","article-title":"The glycolysis inhibitor 2-deoxyglucose ameliorates adjuvant-induced arthritis by regulating macrophage polarization in an AMPK-dependent manner","volume":"140","author":"Cai","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejmech.2026.118922_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2019.04.022","article-title":"Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities","volume":"173","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118922_bib19","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2026.118922_bib20","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/MIB.0000000000001246","article-title":"Genetic and transcriptomic bases of intestinal epithelial barrier dysfunction in inflammatory bowel disease","volume":"23","author":"Vancamelbeke","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejmech.2026.118922_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007984","article-title":"Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment","volume":"4","author":"Arijs","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118922_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222952","article-title":"Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease","volume":"14","author":"Palmer","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118922_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2012-303333","article-title":"Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations","volume":"62","author":"Planell","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2026.118922_bib24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human Colon during ulcerative colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118922_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-Cell analyses inform mechanisms of Myeloid-Targeted therapies in Colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118922_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117058","article-title":"Synthesis, biological evaluation and mechanism study of a novel indole-pyridine chalcone derivative as antiproliferative agent against tumor cells through dual targeting tubulin and HK2","volume":"282","author":"Zheng","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118922_bib27","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1021\/acs.orglett.3c03932","article-title":"Site-Selective synthesis of Antitumor C5-Aminated Indoles via Neighboring Aldehyde Group assisted catellani reaction","volume":"25","author":"Liu","year":"2023","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118922_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103609","article-title":"Structure based discovery of novel hexokinase 2 inhibitors","volume":"96","author":"Liu","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118922_bib29","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171666","article-title":"The catalytic inactivation of the N-half of human hexokinase 2 and structural and biochemical characterization of its mitochondrial conformation","volume":"38","author":"Nawaz","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2026.118922_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-kappaB in inflammation","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.118922_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010234","article-title":"2-Deoxy-d-Glucose and its analogs: from diagnostic to therapeutic agents","volume":"21","author":"Pajak","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:08:02Z","timestamp":1783120082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426003673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0223523426003673"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118922","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of indole-pyridine chalcone derivatives as novel HK2 inhibitors to modulate macrophage glycolysis and inflammation for IBD treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118922"}}